Skip to content

Unravelling the neural network of breathing in myotonic dystrophy: an exploratory study

Unravelling the neural network of breathing in myotonic dystrophy: an exploratory study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26183
Enrollment
50
Registered
2020-11-09
Start date
2021-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myotonic dystrophy type I

Interventions

None

Sponsors

Radboudumc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Healthy subject: competent adult volunteers • Patients: genetically-confirmed adult patients with myotonic dystrophy • Normal or corrected-to-normal vision • Normal uncorrected hearing • Willingness and ability to understand nature and content of the study • Ability to participate and comply with study requirements

Exclusion criteria

Exclusion criteria: • History of or current neurological or psychiatric treatment • History of or current brain surgery or epilepsy • Pregnancy • MRI incompatibility (metal parts in upper body, implants, medical devices or medicinal plasters) • TMS incompatibility (metal parts in head, skin allergies) • Claustrophobia

Design outcomes

Primary

MeasureTime frame
Breathing-task related cerebral activity as a function of breathing condition (rest, paced and loaded) and disease (with or without myotonic dystrophy) measured using fMRI at T=0

Secondary

MeasureTime frame
Other MRI measures (T=0): • T1 structural scan- focal/general (ROI) atrophy with voxel-based measuring of cerebral cortex volume • T2 structural scan- focal/general (ROI) atrophy with voxel-based measuring of cerebral cortex volume • Resting state functional connectivity (seed regions, derived from breathing related fMRI) Physiological measurements inside MRI (T=0): • Breathing rate, and depth is recorded using an pneumotachograph that records airway flow. • Oxygen and carbon dioxide content in expired air is measured using a gas sampling module. • Electrodermal activity (EDA): EDA is a measure of sympathetic autonomic nervous system activation and is measured using Ag/AgCI electrodes placed on the hand • Heart rate (HR): HR is measured using electrocardiography (ECG) using 3 lead electrodes attached to the skin surface, or using a pulse oximeter affixed to a finger. • Tracking of eye gaze and pupil diameter: eye tracking is used to inform about the participant's gaze position and saccade latencies. Pupil diameter is a measure of arousal. • Surface electromyography (EMG): EMG is measured using Ag/AgCI electrodes place on the skin over muscles of interest (diaphragm and intercostal muscles). Physiological measurements outside MRI (T=0): • Forced vital capacity (FVC), force expiratory volume in 1 second (FEV1), maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) • Hypercapnic ventilatory response curve (HCVR): HCVR will be determined using the CO2-rebreathing technique. • Respiratory related evoked potential (RREP): RREP is a measure of cerebral cortical activity elicited by a short inspiratory occlusion. • Transcranial magnetic stimulation (TMS) diaphragm: TMS is an established tool for investigating the corticospinal pathways involved in the control of breathing.

Contacts

Public ContactJonne Doorduin

Radboudumc

jonne.doorduin@radboudumc.nl0650155757

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)